Back to search results

Evaluate the Efficacy and Safety of KK8398 in Patients With Achondroplasia（AOBA Study）

Abroad (travel likely)RecruitingPHASE3

Conditions

Achondroplasia

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

  • Aichi Children's Health and Medical Center, Ōbu, Aichi-ken, Japan

  • Osaka University Hospital, Suita, Osaka, Japan

  • Osaka Women's and Children's Hospital, Waizumi, Osaka, Japan

  • Tokyo Metropolitan Children's Medical Center, Fuchū, Tokyo, Japan

  • Tottori University Hospital, Yonago, Tottori, Japan

  • Niigata University Medical and Dental Hospital, Niigata, Japan

  • Okayama University Hospital, Okayama, Japan

  • ISEIKAI International General Hospital, Osaka, Japan

  • Osaka City General Hospital, Osaka, Japan

Study leads

  • Yu Sato

    Study Director

    Kyowa Kirin Co., Ltd.

View source on ClinicalTrials.gov(opens in a new tab)